Drug
Nanohydroxyapatite
Nanohydroxyapatite is a pharmaceutical drug with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
3
75%
Ph early_phase_1
1
25%
Phase Distribution
1
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Early Phase 1First-in-human
1(25.0%)
N/ANon-phased studies
3(75.0%)
Highest Phase Reached
Early Phase 1Trial Status & Enrollment
Completion Rate
100.0%
4 of 4 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(4)
Detailed Status
Completed4
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Early Phase 1
Trials by Phase
Early Phase 11 (25.0%)
N/A3 (75.0%)
Trials by Status
completed4100%
Recent Activity
0 active trials
Showing 4 of 4
completednot_applicable
Assessment of Rapid Osseointegration of Dental Implants with Different Coatings
NCT06650280
completedearly_phase_1
Evaluation of Platelets Rich Fibrin and Nanohydroxyapatite in the Treatment of Intrabony Defects
NCT02810548
completednot_applicable
Comparision of the Clinical Efficacy of Different Desensitizing Toothpastes
NCT06197555
completednot_applicable
Effect of Nano-hydroxyapatite and LASER on Dentin Hypersensitivity
NCT03637426
Clinical Trials (4)
Showing 4 of 4 trials
NCT06650280Not Applicable
Assessment of Rapid Osseointegration of Dental Implants with Different Coatings
NCT02810548Early Phase 1
Evaluation of Platelets Rich Fibrin and Nanohydroxyapatite in the Treatment of Intrabony Defects
NCT06197555Not Applicable
Comparision of the Clinical Efficacy of Different Desensitizing Toothpastes
NCT03637426Not Applicable
Effect of Nano-hydroxyapatite and LASER on Dentin Hypersensitivity
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4